ALL
37
-3
LRCX
65
6
CME
56
-3
TXN
35
2
ECL
57
-2
TROW
54
-2
EIX
62
-4
AZO
58
-2
HAL
41
2
EOG
36
2
SJM
21
-3
NOV
43
4
CCL
72
2
HSIC
57
4
NRG
40
3
HCP
52
9
EL
37
-3
DLTR
51
-3
URBN
70
-2
MTB
42
-4
ALL
37
-3
LRCX
65
6
CME
56
-3
TXN
35
2
ECL
57
-2
TROW
54
-2
EIX
62
-4
AZO
58
-2
HAL
41
2
EOG
36
2
SJM
21
-3
NOV
43
4
CCL
72
2
HSIC
57
4
NRG
40
3
HCP
52
9
EL
37
-3
DLTR
51
-3
URBN
70
-2
MTB
42
-4
Financhill
Back

Strata Skin Sciences 10K Form

Sell
30

SSKN
Strata Skin Sciences

Last Price:
3.03
Seasonality Move:
-1.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SSKN News And Ratings

See the #1 stock for the next 7 days that we like better than SSKN

SSKN Financial Statistics

Sales & Book Value

Annual Sales: $33.36M
Cash Flow: $-364K
Price / Cash Flow: 0
Annual Sales: $2.24
Price / Book: 1.34

Profitability

EPS (TTM): -2.64000
Net Income (TTM): $-9.38M
Gross Margin: $18.46M
Return on Equity: -82.09%
Return on Assets: -22.44%

Strata Skin Sciences Earnings Forecast

Key Strata Skin Sciences Financial Ratios

  • The Gross Profit Margin over the past 24 years for SSKN is 55.34%.
  • The Selling, General & Administrative Expenses for SSKN have been equal to 70.34% of Gross Profit Margin.
  • The Research & Development expenses have been 3.95% of Revenue.
  • The Interest Expense is -15.14% of Operating Income.
  • The Net Earning history of SSKN is -32.47% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 15 years.

Strata Skin Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: SSKN
CUSIP: 86272A
Website: strataskinsciences.com

Debt

Debt-to-Equity Ratio: 1.62
Current Ratio: 1.13
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SSKN Technical Analysis vs Fundamental Analysis

Sell
30
Strata Skin Sciences (SSKN) is a Sell

Is Strata Skin Sciences a Buy or a Sell?